Details of lipid emulsion use in first week survivors
| Group A (n=51) | Group B (n=54) | |
|---|---|---|
| Duration of lipid (d)3-151 | 20 (12–28) | 6 (2–15)3-150 |
| Mean (SD) % of parenteral time when lipid used | 89 (10) | 29 (22)3-150 |
| Mean (SD) maximal lipid intake (g/kg/d) | 2.4 (0.7) | 1.2 (0.7)3-150 |
| No (%) having lipid stopped | 0 (0) | 13 (30)3-150 |
| No (%) with ⩾1 episodes of hypertriglyceridaemia | 22 (43) | 18 (33) |
| No (%) with ⩾1 episodes of hypercholesterolaemia | 28 (55) | 20 (37) |
| Mean (SD) maximal bilirubin (umol/l) | 174 (41) | 177 (38) |